G+T has advised CleanSpace, a leading Australian designer and manufacturer of workplace respiratory protection equipment, on its IPO and ASX listing, which opened on Friday at $4.41 per share. As at today’s date CleanSpace has a market capitalisation of over $550 million.

CleanSpace was founded in Sydney in 2009 by a team of biomedical engineers and now manufactures innovative respiratory protection products for the global healthcare and industrial sectors. 

Tim Gordon, the Corporate Advisory Partner who led the transaction, said: “it was a pleasure to work with CEO Dr Alexandra Birrell and the team at CleanSpace on their successful listing. It’s fantastic to help bring an Australian manufacturing and technology export success story to the ASX. Given the incredible hardships caused by the COVID 19 pandemic, we’re particularly proud to assist a company that provides best practice respiratory protection for healthcare and industrial workers.  We expect to see great things in the future as CleanSpace continues its success”.

Tim was supported by lawyers Lucy Hall, Matthew Wheatley and Emily Fanning.

Gilbert + Tobin’s market-leading Corporate Advisory team, which boasts some of Australia’s leading M&A and Capital Markets lawyers, has advised on many of Australia’s largest and most innovative transactions. Other recent IPOs include Adore Beauty and MoneyMe. Gilbert + Tobin was ranked 1st in Q3 2020 for number of capital markets deals as legal advisor to the manager by Bloomberg and Refinitiv, and ranked Band 1 in ECM by Chambers Global 2020.